Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Surgical and medical procedures – page 27

  • 434 clinical trials
  • 193 recruiting
  • 295 conditions
  • 27 countries

Conditions in this area

295 conditions with trials, the busiest first

Renal transplant56Allogenic stem cell transplantation19Analgesic therapy18Liver transplant14General anaesthesia12Hip arthroplasty11Postoperative analgesia10Cardiac operation9Haemodialysis9Influenza immunisation9Procedural pain9Prophylaxis against transplant rejection9Atrial fibrillation8Sedative therapy8Palliative care7Prophylaxis7Prophylaxis of nausea and vomiting7Thrombosis prophylaxis7Contraception6Heart transplant6Intensive care6Obesity6Pneumococcal immunisation6Human papilloma virus immunisation5+271

Clinical trials in Surgical and medical procedures

434 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

434 clinical trials

Meningococcal immunisation

Not recruiting

Study on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:TETANUS TOXOID
  • Sponsor:Sanofi Winthrop Industrie

Pertussis immunisation

Not recruiting

Study of Long-term Pertussis Immunity in Children at Age 4 Years Following Maternal Vaccination During Pregnancy

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Sponsor:Varsinais-Suomen hyvinvointialue

Stem cell therapy

Not recruiting

Study on Long-Term Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Patients with Unspecified Conditions

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Cellcolabs AB

Meningococcal immunisation

Not recruiting

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · Healthy volunteers
  • Substances:RNMB1
  • Sponsor:Sanofi Vaccines US Inc.

Contraception

Not recruiting

Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System for Preventing Pregnancy in Women

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Levonorgestrel
  • Sponsor:Chemo Research S.L.

Dental local anaesthesia

Not recruiting

Study on Pain Relief for Dental Procedures in Patients with MC1R Mutation Using Lidocaine-Prilocaine Combination and Lidocaine Alone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Epinephrine
  • Sponsor:Pharmavax AS

Breast cancer+2

Not recruiting

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · Healthy volunteers
  • Substances:Denosumab
  • Sponsor:ANZ Breast Cancer Trials Group Limited

Pneumococcal immunisation

Not recruiting

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1
  • Sponsor:Sanofi Vaccines US Inc.

Hormonal contraception

Not recruiting

Study on the Effects of Hormonal Contraceptives on the Brain: Comparing Drospirenone and Estetrol with Ethinylestradiol and Levonorgestrel in Women Using Contraception

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Region Uppsala

Human papilloma virus immunisation

Not recruiting

Study on the Safety and Immune Response of 9vHPV Vaccine in Preventing HPV in Boys and Girls Aged 9-14 Compared to Young Women Aged 16-26

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Merck Sharp & Dohme LLC

Oral contraception

Not recruiting

Study on the Effects of Ethinylestradiol, Levonorgestrel, and Chlormadinone Acetate in Hormonal Contraception for Women Using Oral Contraceptives

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Ethinylestradiol
  • Sponsor:Paris Lodron Universitaet Salzburg

Meningococcal immunisation

Not recruiting

Study on Immune Response to Meningococcal Vaccine in Elderly with Invasive Meningococcal Disease Using MenACWY-TT Conjugate Vaccine

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Substances studied in this area

The therapies tested most often in Surgical and medical procedures trials.

Sodium Chloride59 clinical trialsTacrolimus32 clinical trialsMycophenolate Mofetil18 clinical trialsPropofol15 clinical trialsParacetamol14 clinical trialsRopivacaine Hydrochloride13 clinical trialsApixaban11 clinical trialsDapagliflozin10 clinical trialsPotassium Chloride10 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.